drugset / Trial / NCT00071253

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

NCT00071253 ↗

Phase 4 Terminated 180 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of continued combination therapy using Depakote plus olanzapine, vs. Depakote monotherapy and olanzapine monotherapy in stable subjects during the maintenance phase of bipolar illness.

Timeline

Start
2003-07
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule — —
Subject Olanzapine Small molecule — —

Indications